Northeast Financial Consultants Inc Frequency Therapeutics, Inc. Transaction History

Northeast Financial Consultants Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	SELL	$0.33 - $0.48 $979 - $1,425	-2,969 Reduced 6.48%	42,857 $14,000
Q1 2022 May 12, 2022	BUY	$1.7 - $5.72 $51,000 - $171,600	30,000 Added 189.56%	45,826 $97,000
Q4 2021 Feb 11, 2022	SELL	$4.95 - $7.11 $126,269 - $181,368	-25,509 Reduced 61.71%	15,826 $81,000
Q2 2021 Aug 16, 2021	BUY	$8.05 - $11.61 $46,899 - $67,639	5,826 Added 16.41%	41,335 $412,000
Q1 2021 May 13, 2021	BUY	$7.99 - $55.01 $238,062 - $1.64 Million	29,795 Added 521.44%	35,509 $337,000
Q4 2020 Feb 12, 2021	BUY	$18.65 - $40.0 $106,566 - $228,560	5,714 New	5,714 $201,000

Ticker FREQ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,262,000
Description
Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules and activate progenitor cells within the body to create functional tissue. The company's lead product candi...

Get notified when there are updates to the investment portfolio of Northeast Financial Consultants Inc, based on Form 13F filings with the SEC.

Stay updated on Northeast Financial Consultants Inc with notifications on news.